-
Why choose Olink for protein biomarker discovery?

Olink news (December 7, 2020)
Olink to provide proteomics data from 53,000 UK Biobank participants
We are proud to announce that the Olink® Explore 1536 platform, utilizing Next Generation Sequencing (NGS) as read-out, will be used in a project to measure plasma protein concentration in 53,000 individuals from the UK Biobank, one of the world’s largest genetic resources. The project is funded by a consortium of ten biopharmaceutical companies.
This large-scale proteomics study will further enhance previous commitments from several consortium members on genomic analyses of the 500,000 volunteers in the UK Biobank resource, with the ultimate goals of developing a better understanding of disease biology and more effective therapies.
Publications
Folkersen et al 2020
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.
Rodriguez et al 2020
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
Su et al 2020
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
Wainberg et al 2020
Multiomic blood correlates of genetic risk identify presymptomatic disease alterations
News & Events Highlights
Precision Medicine and Functional Genomics 2020
Olink VP, Andrea Ballagi will be presenting at the Precision Medicine and Functional Ge...
Systems level immunology webinar by Dr. Petter Brodin
Organized by our friends at Fluidigm, Dr. Petter Brodin will present a webinar,...
On-demand Webinar - Longitudinal plasma proteomics of severe COVID-19
Please watch an exciting and highly topical w...
PEA on NGS, a game-changer for proteomics
June 3, 2020
In our efforts to enable the understanding of real-time hum...
The Olink Community at the Nobel Forum, Stockholm
View the video and get a flavor of the major international meeting, “Precision Proteomics to Drive Personalized Medicine“, which Olink arranged at the Nobel Forum in Stockholm on June 19, 2018. This global event brought together leading scientists from both academia and industry to listen to a series of outstanding presentations and to engage in important discussions around the increasing importance of protein biomarkers for the development of more personalized healthcare.
Please join our community and get #Olinked by following us on LinkedIn